Literature DB >> 34798035

Etrolizumab for ulcerative colitis: beyond what meets the eye.

Manasi Agrawal1, Bram Verstockt2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34798035     DOI: 10.1016/S2468-1253(21)00369-1

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  3 in total

Review 1.  Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation.

Authors:  Sebastian Zundler; Claudia Günther; Andreas E Kremer; Mario M Zaiss; Veit Rothhammer; Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08-09       Impact factor: 73.082

Review 2.  Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician.

Authors:  Adam Saleh; Usman Ansari; Shaadi Abughazaleh; Kerri Glassner; Bincy P Abraham
Journal:  Biologics       Date:  2022-06-17

Review 3.  Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases.

Authors:  Anna Kofla-Dłubacz; Katarzyna Akutko; Elżbieta Krzesiek; Tatiana Jamer; Joanna Braksator; Paula Grębska; Tomasz Pytrus; Andrzej Stawarski
Journal:  J Clin Med       Date:  2022-02-14       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.